Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
3D Medicines, Inc. ( (HK:1244) ) has shared an update.
3D Medicines, Inc. has entered into a Strategic Cooperation Agreement with Qingdao Hainuo, a substantial shareholder of its subsidiary, to discharge a Preservation Order imposed by the Qingdao Intermediate People’s Court. This agreement, valued at RMB98.0 million, aims to improve the company’s financial flexibility and operational efficiency by unfreezing bank accounts and facilitating smoother day-to-day operations, thereby reinforcing the company’s financial stability.
More about 3D Medicines, Inc.
3D Medicines, Inc. operates in the pharmaceutical industry, focusing on developing innovative medical solutions. The company is involved in strategic partnerships and collaborations to enhance its market presence and operational efficiency.
Average Trading Volume: 207,779
Technical Sentiment Signal: Hold
Current Market Cap: HK$1.04B
Learn more about 1244 stock on TipRanks’ Stock Analysis page.